抑肽酶在体外循环心脏瓣膜替换术中的临床应用

您当前的位置：

首页 >

文章列表页 >

更新时间：2024-01-17

- 抑肽酶在体外循环心脏瓣膜替换术中的临床应用
- The cliniacal application of aprotinin in cardiac valve replacement under cardiopulmonary bypass
- 重庆医科大学学报 1997年第1期
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R654
- 纸质出版日期：1997，
扫描看全文
[1]周天荣,房秀生,张幼君.抑肽酶在体外循环心脏瓣膜替换术中的临床应用[J].重庆医科大学学报,1997(01):59-61.

The cliniacal application of aprotinin in cardiac valve replacement under cardiopulmonary bypass[J]. Journal of Chongqing Medical University, 1997,(1).
[1]周天荣,房秀生,张幼君.抑肽酶在体外循环心脏瓣膜替换术中的临床应用[J].重庆医科大学学报,1997(01):59-61. DOI：

The cliniacal application of aprotinin in cardiac valve replacement under cardiopulmonary bypass[J]. Journal of Chongqing Medical University, 1997,(1). DOI：

４０例心脏瓣膜替换术病人随机分为对照组（Ｃ组）和抑肽酶组（Ａ组）。于ＣＰＢ前、ＣＰＢ３０ｍｉｎ和ＣＰＢ后１ｈ分别观察血小板计数、血小板聚集率和血小板粘附率、并记录术后２４ｈ胸腔引流量和输血量。结果表明抑肽酶能有效地保护血小板功能，显著地减少术后出血量和输血量。

\ 40 patients undergoing cardiac valve replacement were divided into two groups:C(Control) N=20;A(Aprotinin n =20 who received 3

000

000 KIU each during CPB.The platelet count

the platelet aggregation and abhesion funcition were determined at three-time points and the first 24 hour postoperative chest drainage

blood transfusion were recorded .The results showed:Aprotinin can provide effective protection for platelet function

markedly reduce postopertive chest drainage and blood transfusion.

体外循环抑肽酶血小板功能

Cardiopulmonary bypssAprotininplatelet function

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

注射用抑肽酶对食管癌围手术期凝血—纤溶系统的影响

妊娠相关性血小板减少症的临床研究